BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30
Bon Natural Life Ltd
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 23, 2026
$1.12−0.02 (-1.51%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.88 (−44.06%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Bon Natural Life Ltd saw revenue fall 21.7% to $18.67M over fiscal 2025. Operating income fell 186.6% to -$1.62M, moving the operating margin from 7.9% to -8.7%. Free cash flow was $134.29K.
Revenue
$18.67M
-21.7% vs. a year earlier
Operating income
-$1.62M
-186.6% vs. a year earlier
Free cash flow
$134.29K
FY2025
EPS, diluted
-$0.72
-117.4% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Sep 30, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $18.67M
- Net income
- -$1.99M
- EPS, diluted
- -$0.72
- Free cash flow
- $134.29K
Seven years at a glance
Fiscal years 2019 to 2025, USD
Revenue
$18.67M-21.7% YoY
Gross profit
$3.88M-45.4% YoY
Operating income
-$1.62M-186.6% YoY
Net income
-$1.99M-601.0% YoY
EPS, diluted
-$0.72-117.4% YoY
Free cash flow
$134.29K
Reported period